Skip to main content
SpringerLink
Log in

Acquired dyschromatopsia in acute myelocytic leukaemia

  • Clinical Case Report
  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Background

Patients with haematological malignancy are referred to the ophthalmologist either with visual symptoms or to exclude orbital or intraocular involvement after the diagnosis has been established. This report describes a patient with acute myelocytic leukaemia (AML) whose presenting symptom was dyschromatopsia.

Methods

A 52-year-old female, previously in good health, presented with a disturbance of colour vision. On examination, there was bilateral reduction in visual acuity, impaired colour vision and severely constricted visual fields. Electrophysiological testing and colour contrast sensitivity (CCS) assessment were performed.

Results

CCS showed bilateral threshold elevation in the tritan axis of both eyes, right worse than left. Pattern ERG showed marked macular dysfunction in the right eye, but was normal in the left eye. Full-field ERGs fell within the normal range. Pattern VEPs were reduced in the right eye, without peak time shift; flash VEPs showed bilateral delay. Investigation showed severe anaemia, and a bone marrow biopsy confirmed a diagnosis of acute AML. There was symptomatic improvement in visual acuity and colour vision following blood transfusion and initiation of chemotherapy.

Conclusion

This appears to be the first case report of dyschromatopsia in AML with symptomatic improvement following treatment. The case lends support to previously suggested hypotheses of chromatic visual disturbance in association with presumed hypoxia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Statistics Of N Cancer Statistics registrations (2010) Registrations of cancer diagnosed in 2007, England. Series MB1 no. 38. National Statistics, London

  2. Sharma T, Grewal J, Gupta S, Murray PI (2004) Ophthalmic manifestations of acute leukaemias: the ophthalmologist’s role. Eye (London) 18(7):663–672

    Article  CAS  Google Scholar 

  3. Reddy SC, Jackson N, Menon BS (2003) Ocular involvement in leukemia—a study of 288 cases. Int J Ophthalmol 217(6):441–445

    CAS  Google Scholar 

  4. Mergler D (1990) Color vision loss: a sensitive indicator of the severity of optic neuropathy. In: Jonson BL (ed) Neurobehavioural toxicology: applications in environmental and occupational health. Lewis, Chelsea, MI

    Google Scholar 

  5. Shin YJ, Park KH, Hwang JM, Wee WR, Lee JH (2007) A new color vision test to differentiate congenital and acquired color vision defects. Ophthalmology 114(7):1341–1347

    Article  PubMed  Google Scholar 

  6. Köllner H (1912) Die Storungen des Farbensinnes, ihre klinischee Bedeutung und ihre Diagnose. Karger, Berlin

    Google Scholar 

  7. Willmann G, Ivanov IV, Fischer MD, Lahiri S, Pokharel RK, Werner A, Khurana TS (2010) Effects on colour discrimination during long term exposure to high altitudes on Mt Everest. Br J Ophthalmol 94(10):1393–1397

    Article  PubMed  Google Scholar 

  8. Kaufman PL, Alm A, Adler FH (2003) Adler’s physiology of the eye: clinical application, 10th edn. Mosby, St. Louis

    Google Scholar 

  9. Kurtenbach A, Schiefer U, Neu A, Zrenner E (1999) Development of brightness matching and colour vision deficits in juvenile diabetics. Vis Res 39(6):1221–1229

    Article  PubMed  CAS  Google Scholar 

  10. Chisholm IA (1972) The dyschromatopsia of pernicious anaemia. Mod Prob Ophthalmol 11:130–135

    CAS  Google Scholar 

  11. McBain VA, Holder GE (2003) Abnormal flash but normal pattern VEP in a cavernous sinus meningioma. Doc Ophthalmol Adv Ophthalmol 107(2):201–202

    Article  Google Scholar 

  12. Heckenlively JR, Arden GB (2006) Principles and practice of clinical electrophysiology of vision, 2nd edn. MIT Press, Cambridge, MA

    Google Scholar 

  13. Birch J (2001) Diagnosis of defective colour vision, 2nd edn. Butterworth–Heinemann, Oxford

    Google Scholar 

  14. Adams P, Chalmers TM, Foulds WS, Withey JL (1967) Megaloblastic anaemia and vision. Lancet 2(7521):894

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

G.E.H. receives research funding from the National Institute of Health Research via the Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Eye Department, University College London Hospital, Third Floor, Central Wing, 250 Euston Road, London, NW1 2PQ, UK

    Mohammed Ziaei, Mostafa A. Elgohary & Fion D. Bremner

  2. Moorfields Eye Hospital, London, UK

    Graham E. Holder

  3. UCL Institute of Ophthalmology, London, UK

    Graham E. Holder

Authors
  1. Mohammed Ziaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graham E. Holder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mostafa A. Elgohary
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fion D. Bremner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed Ziaei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziaei, M., Holder, G.E., Elgohary, M.A. et al. Acquired dyschromatopsia in acute myelocytic leukaemia. Doc Ophthalmol 127, 249–253 (2013). https://doi.org/10.1007/s10633-013-9407-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10633-013-9407-9

Keywords

Search

Navigation